Skip to content

Study · Not a test of the peptide alone · 1990

3 results

[Administration of immunocorrective agents into the greater omentum in the complex treatment of non-circumscribed peritonitis].

Usov SN, Ol'shanetskiĭ AA

Klinicheskaia khirurgiia1 Jan 1990

PMID1692596 (opens in a new tab)PepBankPUB-01692596
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with non-circumscribed peritonitis, complex treatment with intramuscular thymalin had no significant effect on local abdominal immune protection.

    In plain wordsIn patients with peritonitis, complex treatment with intramuscular thymalin did not significantly change local abdominal immune protection.

    Peptide
    Thymalin
    Outcome
    No significant changeLocal immune protection
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Intramuscular injection had no significant effect on the local factors of immune protection of the abdominal cavity.
    1 context sentence
    Summary · context
    Into the complex of treatment of 46 patients with non-circumscribed peritonitis, the thymalin immunocorrector was included.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with non-circumscribed peritonitis, complex treatment with thymalin administered into the great omentum eliminated systemic immunodeficiency.

    In plain wordsIn patients with peritonitis, complex treatment with thymalin into the great omentum eliminated systemic immune deficiency.

    Peptide
    Thymalin
    Outcome
    DecreaseSystemic immunodeficiency
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In thymalin administration into the great omentum, the systemic immunodeficient state and local immunodepression were eliminated.
    1 context sentence
    Summary · context
    Into the complex of treatment of 46 patients with non-circumscribed peritonitis, the thymalin immunocorrector was included.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with non-circumscribed peritonitis, complex treatment with thymalin administered into the great omentum eliminated local immunodepression.

    In plain wordsIn patients with peritonitis, complex treatment with thymalin into the great omentum eliminated local immune suppression.

    Peptide
    Thymalin
    Outcome
    DecreaseLocal immunodepression
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In thymalin administration into the great omentum, the systemic immunodeficient state and local immunodepression were eliminated.
    1 context sentence
    Summary · context
    Into the complex of treatment of 46 patients with non-circumscribed peritonitis, the thymalin immunocorrector was included.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.